Merck KGaA, Darmstadt, Germany, Named a Top Employer by Science Magazine

Merck KGaA, Darmstadt, Germany, today announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication.

20 Oct 2017 | Darmstadt, Germany
  • Survey ranks Merck KGaA, Darmstadt, Germany, fourth among the world’s top employers
  • Current position is the best Merck KGaA, Darmstadt, Germany, has ever held

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication. This ranking marks the fourth year in a row Merck KGaA, Darmstadt, Germany, was named one of the top 20 employers in the healthcare and life science industry. The current ranking is the best ever for Merck KGaA, Darmstadt, Germany, improving from its position of number 11 in 2016. The Healthcare business sector of Merck KGaA, Darmstadt, Germany, operates as EMD Serono in the United States and Canada and the company’s Life Science business sector operates as MilliporeSigma in both countries.

„Science and technology are at the center of everything we do. In global competition for talented employees and experts, this excellent finish in the Science ranking provides good orientation for potential candidates. As a well-known employer, we offer R&D staff an excellent environment for their work,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany.

The Science and Science Careers’ 2017 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics. Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

The rankings, determined from a study conducted by an independent research firm commissioned by the Science/AAAS Custom Publishing Office, will appear in the October 20, 2017 print issue of Science and online on the magazine’s website.


For more Information, contact Gangolf Schrimpf

All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany, generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Related News

  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Provides Update on Xevinapant Program in Locally ...

    Merck KGaA, Darmstadt, Germany, today announced the discontinuation of the Phase III randomized TrilynX study.